BROKERS CHOICE: HAL, NCC, KAYNES, DIVISLAB, HYUNDAI, CREDITACCESS, BHEL, RIL, IDBI, JIOFINANCE, IREDA, ASHOKLEY, YESBANK

MUMBAI, 19 MAY: અગ્રણી બ્રોકરેજ હાઉસ તથા ફંડ હાઉસ તરફથી પસંદગીના સ્ટોક્સમાં ખરીદી\ વેચાણ\ હોલ્ડ કરવા માટે ભલામણ કરવામાં આવી છે. તે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.

Jefferies on HAL: Maintain Buy on Company, raise target price at Rs 6475 versus Rs 4715 (Positive)

JP Morgan on HAL: Maintain Overweight on Company, target price at Rs 6105 (Positive)

CLSA on NCC: Maintain Outperform on Company, target price at Rs 315 (Positive)

Jefferies on Kaynes: Maintain Buy on Company, raise target price at Rs 7660 versus Rs 6660 (Positive)

MS on Divis Lab: Maintain Overweight on Company, target price at Rs 7185 (Positive)

Nuvama on Divis Lab: Maintain Buy on Company, target price at Rs 7225 (Positive)

Nomura on Hyundai: Maintain Buy on Company, raise target price at Rs 2291 (Positive)

CLSA on Hyundai: Maintain Outperform on Company, target price at Rs 2155 (Positive)

Macquarie on Hyundai: Maintain Outperform on Company, target price at Rs 2100 (Positive)

Nomura on Credit Access: Upgrade to Neutral on Company, raise target price at Rs 1090 (Positive)

CLSA on BHEL: Key bright spot was resurgence of fossil orders, given India’s focus on energy security, even as its thermal business orders peaked at 26.6GW in FY25 (Positive)

BofA on Hyundai: Maintain Underperform on Company, raise target price at Rs 1850 (Neutral)

JP Moragn on Hyundai: Maintain Overweight on Company, target price at Rs 2060 (Neutral)

MS on HAL: Downgrade to Equal weight on Company, raise target price at Rs 5092 (Neutral)

CLSA on Credit Access: Downgrade to Underperform on Company, target price at Rs 1050 (Neutral)

GS on Credit Access: Maintain Sell on Company, target price at Rs 700 (Neutral)

Jefferies on Divis Lab: Maintain Hold on Company, target price at Rs 6200 (Neutral)

MS on Kaynes: Downgrade to Equal weight on Company, cut target price at Rs 6155 (Negative)

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)